Development of a disease specific ureteric stone PROM

  • Research type

    Research Study

  • Full title

    Development of a disease specific ureteric stone PROM ("Cambridge Ureteric Stone PROM" CUSP)

  • IRAS ID

    137809

  • Contact name

    Maxine GB Tran

  • Contact email

    maxine.tran@addenbrookes.nhs.uk

  • Sponsor organisation

    Addenbrooke's Hospital NHS Foundation Trust

  • Duration of Study in the UK

    1 years, 11 months, 30 days

  • Research summary

    Outcomes from surgery have traditionally been based on surgeon-reported outcomes such as estimated blood loss, infection rates and length of hospital stay. However, the need for better qualitative assessment has led to an increased interest in outcomes from a patient’s perspective, and patient reported outcome measures (PROMS) are an effective way to do this.

    The NHS PROMS programme initiated in 2009 by the Department of Health has required the routine measurement of PROMs for all NHS patients in England before and after receiving surgery (hernia, hip and knee replacement, and varicose veins), and there is considerable interest for extending measurements to encompass all surgery.

    Although PROMs have been used in Urology, such as the IPSS (International Prostate Symptom Score), a systematic review of the literature did not identify a formally validated PROM for ureteric calculi; one of the commonest urological emergencies.

    The aim of the project is to develop a disease specific ureteric calculus PROM instrument, with the plan of using it together with a generic PROM (EQ5D5L) in a prospective study of ureteric calculi therapy (comparison of conservative, ESWL, primary and elective URS).
    We have conducted patient focus groups and structured interviews to gather input from over 24 patients for our ureteric stone PROM. All patients comments have been transcribed and important 'themes' identified by patients have been examined to select appropriately weighted questions from Question Banks from the PROMIS health organisation and the FACIT organisation.
    We would like to proceed to validate our PROM. This will provide important insight into the impact that ureteric stones have on patients and it will enable for the first time, a patient reported comparison of the current three main management options for ureteric stones.

  • REC name

    HSC REC A

  • REC reference

    14/NI/1111

  • Date of REC Opinion

    20 Oct 2014

  • REC opinion

    Further Information Favourable Opinion